Announcement on Participating in Setting up Private Equity Investment Fund
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Participating in Setting up Private Equity Investment Fund
Filed with SSE · · 11 pages · Chinese
Release
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. on 6ix
Earlier from Shanghai Fosun Pharmaceutical (Group)
- Announcement on Proposed Expansion of Financial Leasing Business by a Holding Subsidiary
- Announcement on Resolutions of the Convening of the 2026 1st Extraordinary General Meeting, the 2026 1st A-share General Meeting and the 2026 1st H-share General Meeting
- Self-Inspection Report on Trading of the Company's Shares by Insiders Related to the Spin-off and Listing of a Subsidiary on the Main Board of the Stock Exchange of Hong Kong Limited
- Announcement on Progress in Signing the Licensing Agreement of Wholly-owned Subsidiary
- Announcement on Signing License Agreement by Holding Subsidiary
Later from Shanghai Fosun Pharmaceutical (Group)
- Announcement on Change of Chief Financial Officer
- Announcement on Approval of Supplementary Drug Application by Holding Subsidiary
- Announcement on the Pledge of Partial Shares Held by Shareholders
- Fosun Health เสริมความแกร่งระดับภูมิภาคที่ GlobalHealth Asia-Pacific Forum 2026 อวด "China Solution" พร้อมกวาดสามรางวัลใหญ่
- Announcement on Progress in Participation in Establishing a Private Equity Investment Fund and Proposed Disposal of Assets
Follow Shanghai Fosun Pharmaceutical (Group) into a list and get an email when it puts out news.
Follow Shanghai Fosun Pharmaceutical (Group)